Surgeon/investigator: MOMENTUM 3 trial results represent a major advance in the field of LVAD therapy


Expert Pitch

Francis Pagani, M.D., Ph.D., co-author on MOMENTUM 3 trial of LVAD (left ventricular assist device) therapy/ cardiac surgeon at Michigan Medicine (University of Michigan) comments on importance of this late-breaking clinical trial at the American College of Cardiology Scientific Sessions.

"The MOMENTUM 3 trial represents the largest study ever performed evaluating an implantable left ventricular assist device.  The results from the MOMENTUM 3 demonstrate a significant reduction in important adverse events such as pump thrombosis, stroke and major bleeding for the HeartMate 3 compared to the HeartMate II. The overall improvement in outcomes obtained with the HeartMate 3 represents a major advance in the field of LVAD therapy and is important in achieving greater benefit for our patients."

New England Journal of Medicine article published simultaneously: https://www.nejm.org/doi/full/10.1056/NEJMoa1900486

Pagani's bio/credentials: https://www.umcvc.org/profile/397/francis-dominic-pagani-md

  • share-facebook-Surgeon/investigator: MOMENTUM 3 trial results represent a major advance in the field of LVAD therapy
  • share-twitter-Surgeon/investigator: MOMENTUM 3 trial results represent a major advance in the field of LVAD therapy

Comment/Share

step 2
Chat now!